Cannabis and WADA — the current rules

TL;DR

  • THC is banned only IN competition (class S8).
  • Urinary threshold: 150 ng/mL carboxy-THC.
  • CBD has been exempt since 2018 — watch for residual THC.
  • Out-of-competition: no THC ban.

What applies in Switzerland?

Antidoping Switzerland adopts the WADA list 1:1. For licensed athletes: use > ~48-72 h before competition is usually safe, but chronic use is risky — carboxy-THC stays detectable for weeks (Docter 2020).

CBD & the THC contamination trap

CBD itself is allowed, but Swiss full-spectrum oils often contain < 1% THC. Athletes on high daily CBD doses have produced positive urinary THC tests (Lachenmeier 2019). Prefer isolate or certified 'THC-free' products.

The pharmacokinetic background of the WADA thresholds

The pharmacokinetics of tetrahydrocannabinol present a particular challenge for competitive athletes. After consumption, THC is rapidly metabolized, producing, among other things, the inactive metabolite THC-carboxylic acid, which is detected in urine. Since THC is highly lipophilic, it accumulates in the body's adipose tissue. During intensive training, fasting, or dehydration, this stored THC can be released back into the bloodstream and thus into the urine. This process is highly individual and can hardly be calculated precisely in terms of timing.

The threshold of 150 nanograms per milliliter in urine established by WADA is primarily intended to detect active consumption during competition. Nevertheless, this comparatively high threshold does not reliably protect chronic users from a positive test result. Since excretion is irregular, residual amounts of the metabolite can still exceed the critical limit weeks after the last consumption. Athletes must be aware that physical stress can reactivate the release from adipose tissue, increasing the risk of an unintentional doping finding in competition.

  • Lipophilic character: THC accumulates in adipose tissue and is released with a delay.
  • Unpredictable excretion: Physical exertion can influence renal excretion.
  • Detection limit: The threshold focuses on acute in-competition consumption.
  • Individual factors: Metabolic rate and body fat percentage determine the detection window.

Legal and regulatory classification in Swiss sports

In Switzerland, the Swiss Sport Integrity foundation monitors compliance with anti-doping regulations in accordance with international WADA guidelines. Although the Swiss Narcotics Act legalizes products with a total THC content of less than one percent, this national legislation does not protect athletes from sanctions under sports law. In sports, the principle of strict liability applies. An athlete is solely responsible for ensuring that no prohibited substances enter their body. A CBD product legally purchased in Switzerland with minor traces of THC can therefore directly lead to a ban.

Strict rules apply to patients who require medical cannabis. Although medical cannabis has been prescribable by doctors in Switzerland without an exceptional authorization from the BAG since August 2022, THC remains a prohibited substance in organized sports. Athletes who rely on THC-containing preparations for medical reasons must apply for a therapeutic use exemption. This authorization is only granted by Swiss Sport Integrity under strict conditions, if no therapeutic alternatives exist and no performance enhancement is to be expected.

  • Swiss Sport Integrity: National authority for the implementation of WADA guidelines.
  • Strict liability: Athletes bear the sole risk for positive tests.
  • Legal contradiction: Swiss hemp thresholds do not protect against doping sanctions.
  • Therapeutic Use Exemption: TUE procedure is mandatory for therapeutic THC use.

Risk analysis for CBD products and food supplements

The market for cannabidiol products poses significant risks for tested athletes, as quality controls in the food supplements sector are often insufficient. Many over-the-counter CBD oils and extracts are manufactured using incomplete purification processes, leaving measurable amounts of THC in the final product. Since WADA has excluded only pure CBD from the Prohibited List, any contamination with other cannabinoids leads to a potential violation during a test. Declarations such as "THC-free" are not strictly protected by law and do not offer absolute security.

To minimize the risk of an inadvertent doping ban, athletes should completely avoid the consumption of full-spectrum products. These naturally contain the entire spectrum of the hemp plant, including small amounts of THC. Highly pure CBD isolates certified by independent laboratory analyses are considered a safer alternative. Nevertheless, a residual uncertainty remains here as well, which is why many sports associations generally advise their athletes against consuming any cannabis products in order not to jeopardize their sporting careers through inadequate product declarations.

  • Lack of regulation: Food supplements often exhibit labeling deficiencies.
  • Full-spectrum danger: Natural extracts almost always contain prohibited residual cannabinoids.
  • Certified isolates: Only batch-tested pure substances minimize the risk of contamination.
  • Association recommendations: General avoidance is advised by many sports organizations.

FAQ

Am I tested as a hobby athlete?

Only if you're licensed with a federation subject to anti-doping statutes (Swiss Athletics, Swiss Cycling…).

How do Swiss athletes apply for a Therapeutic Use Exemption (TUE) for medical cannabis?

Swiss athletes must submit their application for a Therapeutic Use Exemption (TUE) directly to Swiss Sport Integrity. The application requires comprehensive medical documentation from the treating physician. It must be proven that a diagnosed medical condition exists, that treatment with medical cannabis is necessary, and that no permitted therapeutic alternatives are effective. Furthermore, the medication must not have any performance-enhancing effect. Ideally, the application should be submitted before the start of therapy.

Why is the WADA threshold for THC in urine set at 150 ng/mL and not at zero?

The relatively high threshold of 150 nanograms per millilitre of carboxy-THC in urine was established by WADA to differentiate active consumption immediately before or during a competition from passive exposure or consumption that occurred long ago. A lower threshold would result in athletes testing positive due to passive smoking or residual amounts consumed days earlier. The threshold is therefore intended to prevent inadvertent doping findings, while abuse on the day of competition remains sanctioned.

Does the WADA cannabis ban also apply to synthetic cannabinoids?

Yes, synthetic cannabinoids are strictly prohibited under category S8 (Cannabinoids) of the WADA Prohibited List. This includes all synthetically produced substances that mimic the effects of THC in the body, such as Spice or K2. In contrast to natural CBD, which is explicitly permitted, there are no exceptions for synthetic variants. Since these substances often carry unpredictable health risks and can influence performance, their detection in competition leads to disciplinary proceedings without exception.